Coherus BioSciences announces passing of board member Dr. Samuel Nussbaum

Coherus Oncology, Inc.

Dr. Samuel Nussbaum passed away on September 23, 2021.
He had served as a director of Coherus since May 2018.
CEO Denny Lanfear expressed gratitude for Dr. Nussbaum's guidance and support.
Dr. Nussbaum was former EVP, Chief Medical Officer at Anthem from 2000 to 2016.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Samuel Nussbaum

Member of the Board of Directors

CHRS · Coherus Oncology, Inc.

Effective: 2021-09-23
Filed: September 29, 2021, 7:59 PM ET

Samuel Nussbaum, M.D., a member of the Company’s Board of Directors, passed away on Thursday, September 23, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Samuel Nussbaum departed as Member of the Board of Directors at Coherus Oncology, Inc..

Action: passed away
Role: Member of the Board of Directors

Exact text from the filing

Samuel Nussbaum, M.D., a member of the Company’s Board of Directors, passed away on Thursday, September 23, 2021.

View on SEC.gov

Coherus Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-286870

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.